Summary

Eligibility
for people ages 18-75 (full criteria)
Location
at UCLA
Dates
study started
estimated completion

Description

Summary

This study will evaluate the efficacy and safety of BOTOX® intravesical instillation in participants with overactive bladder and urinary incontinence.

Official Title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-treatment, 2-stage, Dose-finding Study Evaluating the Efficacy and Safety of BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence

Keywords

Urinary Incontinence Overactive Bladder With Urinary Incontinence Enuresis Urinary Bladder, Overactive Botulinum Toxins Botulinum Toxins, Type A abobotulinumtoxinA OnabotulinumtoxinA and Hydrogel admixture

Eligibility

You can join if…

Open to people ages 18-75

  • Symptoms of OAB (frequency/urgency) with urinary incontinence for at least 6 months
  • Inadequate response or limiting side effects with pharmacotherapy for the treatment of OAB

You CAN'T join if...

  • Overactive Bladder caused by neurological condition
  • Patient has predominance of stress incontinence
  • History or evidence of pelvic or urological abnormality
  • Prior use of BOTOX for any urological condition

Locations

  • Wr-McCr, Llc
    San Diego California 92108 United States
  • San Diego Clinical Trials
    San Diego California 92120 United States
  • Hope Clinical Research
    Canoga Park California 91303 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Allergan
Links
Additional information on study locations near you may be found at AllerganClinicalTrials.com.
ID
NCT03320850
Phase
Phase 2
Study Type
Interventional
Last Updated